BNP Paribas Financial Markets’s Kyverna Therapeutics KYTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.6K Sell
4,431
-41,950
-90% -$129K ﹤0.01% 3942
2025
Q1
$89.5K Buy
46,381
+1,398
+3% +$2.7K ﹤0.01% 3244
2024
Q4
$168K Buy
44,983
+17,786
+65% +$66.5K ﹤0.01% 3115
2024
Q3
$133K Buy
27,197
+25,997
+2,166% +$127K ﹤0.01% 2669
2024
Q2
$9K Buy
+1,200
New +$9K ﹤0.01% 3050